Institute of Bioengineering and Bioimaging (IBB)
A*STAR scientists develop an optoacoustic imaging technology for diagnosing disease by assessing subtle blood flow changes in the skin.
Ushering in an era of targeted precision medicine, scientists across A*STAR are propelling the research, commercialisation and implementation of RNA-based therapeutics.
By identifying the best way to decontaminate N95 masks, A*STAR scientists are helping solve the environmental consequences of disposable masks.
A phenomenon called superferromagnetism boosts the resolution of magnetic particle imaging.
A*STAR scientists developed self-sanitizing surfaces capable of eliminating microbes effectively within mere minutes.
Researchers have identified a stem cell marker that influences fat cell development, unlocking exciting therapeutic opportunities for chronic diseases.
A novel polymer improves the effectiveness of chemotherapeutics against drug-resistant tumors.
A newly-designed antimicrobial polymer offers a 2-in-1 solution to combat multidrug-resistant bacteria.
A novel 3D printing method developed by A*STAR researchers fabricates soft support for tissue growth, with embedded channels that ensure nutrient supply.
A*STAR scientists are developing the next generation of self-sanitizing surfaces by mimicking nanostructures on cicada wings.
Scientists have identified a network of neurons that drives overeating in response to environmental cues, rather than genuine hunger.
From expanding the genetic alphabet to uncovering antibiotics hidden in silent genes, A*STAR’s researchers are wielding the tools of synthetic biology to improve our lives in surprising ways.